Vesticarpan is primarily used in the development of targeted cancer therapies. It functions as a stabilizing agent in nanoparticle-based drug delivery systems, helping to improve the circulation time and tumor accumulation of chemotherapeutic agents. Due to its ability to enhance membrane permeability and support controlled release, it is employed in formulations designed to reduce systemic toxicity and increase the efficacy of anticancer drugs. It is also being explored in diagnostic imaging applications, where it aids in the delivery of contrast agents to specific tissue sites. Its compatibility with biodegradable polymers makes it suitable for use in implantable or injectable delivery platforms currently under investigation for personalized medicine approaches.